LeMaitre Vascular, Inc.
LMAT
$112.23
$1.481.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 249.60M | 240.87M | 234.64M | 226.26M | 219.86M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 249.60M | 240.87M | 234.64M | 226.26M | 219.86M |
| Cost of Revenue | 76.46M | 72.63M | 72.48M | 70.60M | 68.96M |
| Gross Profit | 173.14M | 168.24M | 162.16M | 155.66M | 150.90M |
| SG&A Expenses | 100.09M | 96.58M | 92.48M | 87.00M | 83.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 191.29M | 183.73M | 179.87M | 173.25M | 167.61M |
| Operating Income | 58.31M | 57.13M | 54.77M | 53.01M | 52.26M |
| Income Before Tax | 75.18M | 68.91M | 60.88M | 58.32M | 56.88M |
| Income Tax Expenses | 17.45M | 15.57M | 13.77M | 13.16M | 12.84M |
| Earnings from Continuing Operations | 57.73 | 53.34 | 47.12 | 45.16 | 44.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.73M | 53.34M | 47.12M | 45.16M | 44.04M |
| EBIT | 58.31M | 57.13M | 54.77M | 53.01M | 52.26M |
| EBITDA | 68.73M | 67.36M | 64.81M | 62.79M | 61.86M |
| EPS Basic | 2.55 | 2.36 | 2.09 | 2.01 | 1.96 |
| Normalized Basic EPS | 1.81 | 1.77 | 1.69 | 1.62 | 1.58 |
| EPS Diluted | 2.51 | 2.31 | 2.05 | 1.97 | 1.93 |
| Normalized Diluted EPS | 1.76 | 1.72 | 1.66 | 1.60 | 1.56 |
| Average Basic Shares Outstanding | 90.55M | 90.35M | 90.17M | 90.01M | 89.81M |
| Average Diluted Shares Outstanding | 93.15M | 93.09M | 91.53M | 91.36M | 91.03M |
| Dividend Per Share | 0.80 | 0.76 | 0.72 | 0.68 | 0.64 |
| Payout Ratio | 31.37% | 32.20% | 34.45% | 33.89% | 32.65% |